[Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin)].
作者信息
Di Matteo L, D'Incecco V, Evangelista L, Castiglione C, Consoli G
出版信息
Boll Soc Ital Biol Sper. 1985 May 30;61(5):777-81.
PMID:3927943
Abstract
摘要
相似文献
1
[Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin)].
Boll Soc Ital Biol Sper. 1985 May 30;61(5):777-81.
2
3
Oral gold therapy in rheumatoid arthritis: auranofin.
Am J Med. 1983 Dec 30;75(6A):1-164.
4
5
Long term auranofin treatment in rheumatoid arthritis.
J Rheumatol. 1985 Jun;12(3):620-2.
6
Effect of auranofin on DNA and protein synthesis in human lymphocytes.
J Rheumatol. 1977 Autumn;4(3):245-51.
7
[Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].[金诺芬。作用机制、药代动力学及临床应用。与注射用金盐的比较]
Rev Rhum Mal Osteoartic. 1985 Apr;52(4):277-82.
8
The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.类风湿关节炎患者在金诺芬治疗失败后接受胃肠外金制剂治疗的疗效。
J Rheumatol. 1983 Aug;10(4):664.
9
[Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
Wien Klin Wochenschr Suppl. 1984;156:49-51.
10
Auranofin: more than just oral gold.金诺芬：不止是口服金剂。
Clin Pharm. 1984 Mar-Apr;3(2):195.
Zotero 插件